Breaking news!! Oxford's corona vaccine is in October ,scientists say effort is ongoing

When will the coronavirus vaccine come? This is now the biggest question for people in all parts of the world. The world is looking at scientists and researchers. No one has yet announced the exact date of the vaccine.However, experts agree that the scientists at Oxford University are a few steps ahead of everyone else. This coronavirus vaccine, developed by Oxford scientists, is exceptional not only in terms of clinical trials but also in results.

According to medical science, the two essential components of any vaccine are the production of antibodies and the T-cell response. Why? Antibodies identify the virus in the body and fight against it and destroy the effectiveness of the virus and T-cells not only help make antibodies, they also work on infected cells and inactivate the virus. These T-cells are very effective in diseases like measles, cold and cough.

Once someone is infected with a virus, the memory cells of that virus remain in their cells. The next time you come in contact with the virus, the memory cells are infected first. Various studies have shown that antibodies do not stay in the human body for very long. But these T-cells stay in the body for many years.The next time you are infected with the virus, it is these T-cells that fight the virus and destroy its function.

Oxford researchers, led by Sarah Gilbert, claim that their coronavirus vaccine is capable of producing T-cells. Many companies in the world like Modernna, Pfizer, Bioentech are running after the invention of vaccine. Some of them have started the first or second phase clinical trial or experimental application.But none of them have yet claimed that ‘T-cells’ are being made with antibodies in their vaccines. Besides, there is no evidence of any side effects in the experimental data.

According to a senior scientist involved in vaccine development, an Indian media outlet claimed that the vaccine developed by the Oxford Jenner Institute contained both antibodies and T-cells.Scientists believe that this is where Oxford's uniqueness and rapid success can be achieved. According to Jonathan Ball, professor of virology at the University of Nottingham, "I can only say that if a vaccine is able to produce both of these components (antibodies and T-cells), then other vaccines will be ahead of those that produce one component." . ''

The director of the London School of Hygiene and Tropical Medicine is not in favor of being so pessimistic about other vaccines. According to him, the idea that vaccines that cannot make T-cells are not effective is not correct.The presence of antibodies in the body may be less than the number of antibodies present in the test. However, this does not mean that the second time the same virus can not fight against it. On the other hand, there is no reason to think that a person is safe if they have T-cells in their body.

But ordinary people no longer want to understand the complexities of medical science. They want to know when the coronavirus vaccine will be discovered and made available to the general public. It is rumored that the Oxford vaccine will be available next week.But a US health official told a TV channel on Wednesday that it would be "very good" if the vaccine was introduced this year. But I think it will be 2021.

The Oxford vaccine was approved by the Berkshire Research Ethics Committee. David Carpenter, the agency's chairperson, said no one could predict the final date. Disagreements can arise at any time. But in reality the vaccine could be made in September. They are advancing along that dateline.

The vaccine was administered to 500 people in the first phase of experimental application to the human body. Analyzing the results, the scientists claim that the issue of antibodies and T-cells has come up. Brazil is currently in the process of applying it to over 5,000 people and collecting its results.The deal with the British pharmaceutical company AstraZeneca for commercial production of the vaccine has also expired. Initially, the company will produce 20 million doses. Scientists at Oxford are hoping that if all goes well, the vaccine could be developed in October.

On the other hand, Sarah Gilbert, led by optimistic Oxford scientists. She says that if applied to people infected with coronavirus, they have a 60 percent chance of recovery and she has been working hard since the beginning of making this vaccine. She said he woke up at four in the morning., works a few hours at home. Then go to the office by bicycle. She stays there till evening. May her efforts be successful, that is what the world is praying for.